Oral neltenexine in patients with obstructive airways diseases: An open, randomised, controlled comparison versus sobrerol

Minerva Medica

Volumn 92, Issue 4, 2001, Pages 269-275

  Fadda, G ^a  

^a Ospedale Alivesi   (Italy)

Author keywords

Expectorants; Lung diseases, obstructive, drug therapy; Respiratory system agents

Indexed keywords

ALVEOTEN; AMBROXOL; AMINOPHYLLINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CARBOXYLIC ACID DERIVATIVE; CORTICOSTEROID; MUCOLYTIC AGENT; NELTENEXINE; SOBREROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG GRANULE; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; HUMAN; MALE; NAUSEA AND VOMITING; OBSTRUCTIVE AIRWAY DISEASE; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; VOMITING;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; AMBROXOL; EXPECTORANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TERPENES;

EID: 0034783232     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Guidelines for the management of chronic obstructive pulmonary disease
2. What's in a name?
3. Tosse come meccanismo di depurazione
4. Classification of agents that act on bronchial mucous
5. Mucoregolazione farmacologica dell'epitelio respiratorio
6. Bioavailability of neltenexine
7. Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
8. Prevention of chronic bronchitis exacerbations with ambroxol (mucosolvan retard). An open, longterm, multicenter study in 5,635 patients
9. Oral fabrol (oral N-aceylcysteine) in chronic bronchitis
10. Prevention of acute exacerbations of chronic bronchitis with carbocysteine lysine salt monohydrate: A multicenter, double-blind, placebo controlled trial
11. Changing attituted and strategies in COPD management